| CGTX Stock | | | USD 0.45 0.03 7.14% |
Cognition Therapeutics financial indicator trend analysis is way more than just evaluating Cognition Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cognition Therapeutics is a good investment. Please check the relationship between Cognition Therapeutics Total Assets and its Non Current Liabilities Total accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Cognition Stock please use our
How to Invest in Cognition Therapeutics guide.
Total Assets vs Non Current Liabilities Total
Total Assets vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cognition Therapeutics Total Assets account and
Non Current Liabilities Total. At this time, the significance of the direction appears to have pay attention.
The correlation between Cognition Therapeutics' Total Assets and Non Current Liabilities Total is -0.94. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Cognition Therapeutics, assuming nothing else is changed. The correlation between historical values of Cognition Therapeutics' Total Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Cognition Therapeutics are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Assets i.e., Cognition Therapeutics' Total Assets and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | -0.94 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of Cognition Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cognition Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Non Current Liabilities Total
Most indicators from Cognition Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cognition Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Cognition Stock please use our
How to Invest in Cognition Therapeutics guide.
Issuance Of Capital Stock is likely to rise to about 11.5
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 9.8
M in 2024.
Cognition Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Cognition Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to
measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.